PositiveID Corporation's CEO to Present at InvestorIdeas.com Security and Defense Conference on March 11, 2014 in New York Ci...
06 March 2014 - 12:30AM
PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a
developer of biological detection and diagnostics solutions, today
announced that its Chairman and CEO, William J. Caragol, will
present at the InvestorIdeas.com Security and Defense Conference at
3:30 pm on March 11, 2014, at the New York Hilton Midtown in New
York City. The Company's presentation will be posted in the
Investors & Media section of its website under Events &
Presentations.
Mr. Caragol will discuss PositiveID's M-BAND and Firefly
products. M-BAND (Microfluidic Bio-agent Autonomous Networked
Detector), a proprietary airborne pathogen detection system, was
developed under contract with the U.S. Department of Homeland
Security ("DHS") Science & Technology directorate and $30
million of contract funding. M-BAND continuously and autonomously
analyzes air samples for the detection of biological airborne
threats in the form of bacteria, viruses, and toxins. M-BAND
is positioned to capitalize on the next generation of BioWatch, the
U.S. government's $3-5 billion program to detect the release of
pathogens into the air as part of a defense against potential
terrorist attacks.
Firefly Dx is a point-of-need, handheld system designed to
deliver molecular diagnostic results using real-time TaqMan® PCR
(polymerase chain reaction) chemistry. Firefly is being developed
to meet the growing need in healthcare and molecular diagnostics
markets for more rapid and accurate point-of-need diagnostics that
will enable hospitals, physicians and other providers to save more
lives. Firefly can derive results from a sample in less than 20
minutes, at the point of need, compared to two to four hours for a
lab device, which would enable accurate diagnostics leading to more
rapid and effective treatment than what is currently available with
existing systems at a far lower upfront cost and cost per test.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and
developer of biological detection systems for America's homeland
defense industry as well as rapid biological testing. PositiveID is
focused on the development of microfluidic systems for the
automated preparation of and performance of biological assays in
order to detect biological threats and analyze biological samples.
For more information on PositiveID, please visit
http://www.PositiveIDCorp.com.
Statements about PositiveID's future expectations including,
without limitation, the likelihood that Firefly is being developed
to meet the growing need in healthcare and molecular diagnostics
markets for more rapid and accurate point-of-need diagnostics that
will enable hospitals, physicians and other providers to save
lives; the likelihood that Firefly would enable accurate
diagnostics leading to more rapid and effective treatment than what
is currently available with existing systems; constitute
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Litigation
Reform Act of 1995. Such forward-looking statements involve risks
and uncertainties and are subject to change at any time, and
PositiveID's actual results could differ materially from expected
results. Additional information about these and other factors that
could affect the Company's business is set forth in the Company's
various filings with the Securities and Exchange Commission,
including those set forth in the Company's 10-K filed on April 16,
2013, and 10-Qs filed on May 20, 2013, August 14, 2013, as amended
August 19, 2013, and November 19, 2013, under the caption "Risk
Factors." The Company undertakes no obligation to update or release
any revisions to these forward-looking statements to reflect events
or circumstances after the date of this statement or to reflect the
occurrence of unanticipated events, except as required by law.
CONTACT: PositiveID Corporation
Allison Tomek
561-805-8000
atomek@positiveidcorp.com